Human Antithrombin III
The research report includes specific segments by region (country), by company, by Form and by Ap ... Read More
The research report includes specific segments by region (country), by company, by Packaging and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Packaging
500 IU Factor IX/Bottle (20ml)
1000 IU Factor IX/Bottle (40ml)
Segment by Application
Prevent Bleeding Episodes in People with Factor IX Deficiency
Treat Bleeding Episodes in People with Factor IX Deficiency
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Grifols
CSL Behring
Alpha Therapeutic Corp
Octapharma AG
Baxter International Inc
Hualan Biological Engineering
Shanghai Raas Blood Products Co. Ltd
China Biologic Products Holdings, Inc
The research report includes specific segments by region (country), by company, by Form and by Ap ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Lengths ... Read More